Trader consensus prices a 69% implied probability against Bryan Johnson proposing to Blueprint co-founder Kate Tolo before the end of 2026, reflecting the absence of any engagement signals despite their deepening public intimacy. In his December 2025 announcement, the longevity pioneer described their three-year relationship as a puzzle-piece fit forged at neurotech firm Kernel, evolving into Blueprint's core partnership—likening Tolo to his "Abigail Adams" ideal—yet omitted marriage plans amid his past failed arranged union. Recent shares, like Tolo's top 1% vaginal microbiome via Blueprint protocols in April 2026, underscore biohacking closeness without proposal hints. Johnson's unyielding anti-aging regimen and AI-biotech focus sustain trader doubts, with direct statements as potential catalysts.